Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Prabhat Ghanshyam Bhargava"'
Autor:
Jyoti Bajpai, George Abraham, Avanish P. Saklani, Anshul Agarwal, Sashanka Das, Ambarish Chatterjee, Akhil Kapoor, Prathyusha Eaga, Pradip Kumar Mondal, Arun Chandrasekharan, Prabhat Ghanshyam Bhargava, Sujay Srinivas, Siddharth Turkar, Bharat Rekhi, Nehal Khanna, Amit Kumar Janu, Munita Bal, Vikas Sureshchand Ostwal, Anant Ramaswamy, Jitender Rohila, Ashwin L. Desouza, Amrita Guha, Rajiv Kumar, Nandini Sharrel Menon, Sushmita Rath, Vijay Maruti Patil, Vanita Maria Noronha, Amit Prakashchandra Joshi, Siddhartha Laskar, Venkatesh Rangarajan, Kumar Prabhash, Sudeep Gupta, Shripad Banavali
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundTreatment of malignant melanoma has undergone a paradigm shift with the advent of immune checkpoint inhibitors (ICI) and targeted therapies. However, access to ICI is limited in low-middle income countries (LMICs).Patients and MethodsHistol
Externí odkaz:
https://doaj.org/article/09b0201bc3804bcf8f43a6dd061e0ff6
Autor:
Ramjas Prajapati, Sujay Srinivas, Vikas S Ostwal, Prabhat Ghanshyam Bhargava, Reena Engineer, Rahul Krishnatry, Zoya Peelay, Ashwin Luis Desouza, Avanish Saklani, Suman Kumar Ankathi, Manali Parulekar, Anant Ramaswamy
Publikováno v:
Journal of Clinical Oncology. 40:108-108
108 Background: There is limited data with regard to the use of modified 5-fluoroural-leucovorin-irinotecan-oxaliplatin (mFOLFIRINOX) in enabling resection and increasing survival of locally advanced rectal adenocarcinomas (LARC) with high-risk chara